ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Stock Cash Flow
NASDAQ:ADAP - Nasdaq - US00653A1079 - ADR - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -44.52M | -113.87M | -165.46M | -158.09M | -130.09M | |||
| Depreciation Amortization | 11.26M | 9.84M | 6.08M | 6.57M | 7.60M | |||
| Change In Working Capital | -34.25M | -24.95M | -1.53M | 134.63M | 56.05M | |||
| Taxes Paid | N/A | 4.00M | 630.00K | 540.00K | 80.00K | |||
| Other non cash items | 13.82M | -11.90M | 19.14M | 27.62M | 12.86M | |||
| OPERATING CASH FLOW | -53.68M | -140.88M | -141.77M | 10.73M | -53.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.38M | -4.88M | -29.74M | -8.78M | -2.91M | |||
| Other Investing Activity | N/A | 181.42M | 118.88M | 84.58M | -276.02M | |||
| INVESTING CASH FLOW | 1.08M | 176.54M | 89.14M | 75.80M | -278.92M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 29.32M | 880.00K | 12.87M | 3.29M | 340.05M | |||
| FINANCING CASH FLOW | 78.82M | 880.00K | 12.87M | 3.29M | 340.05M | |||
| Exchange Rate Effect | 125.00K | 877.00K | -2.30M | 370.00K | -960.00K | |||
| CHANGE IN CASH | 26.34M | 37.42M | -42.06M | 90.19M | 6.58M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -53.68M | -140.88M | -141.77M | 10.73M | -53.59M | |||
| Capital Expenditure | -2.38M | -4.88M | -29.74M | -8.78M | -2.91M | |||
| FREE CASH FLOW | -56.06M | -145.76M | -171.51M | 1.95M | -56.50M | |||
All data in USD